| Cat. No. |
Product Name |
Information |
| PC-38835 |
DI-87
dCK inhibitor
|
DI-87 ((R)-DI-87) is a highly potent, specific, orally bioavailable deoxycytidine kinase (dCK) inhibitor with IC50 of 3.15 nM. |
| PC-38579 |
3-Deazauridine
CTP inhibitor
|
3-Deazauridine (DAU, NSC 126849) is a nucleoside analog that competitively inhibits cytidine triphosphate synthetase (CTP). |
| PC-38453 |
YMU1
hTMPK inhibitor
|
YMU1 is a specific, cell-permeable inhibitor of human thymidylate kinase (hTMPK) with IC50 of 0.61 uM in enzymatic assays. |
| PC-72499 |
N6-benzyladenosine
DNPH1 inhibitor
|
N6-benzyladenosine (DNPH1i, N6-benzyl-AMP) is a nucleoside analog that acts as competitive inhibitor of deoxynucleotide N-hydrolase DNPH1. |
| PC-72483 |
MRT00252040
PAICS inhibitor
|
MRT00252040 (PAICSi) is a small molecule inhibitor PAICS, which catalyzes two steps in the de novo purine synthesis pathway. |
| PC-36085 |
Aspacytarabine
|
Aspacytarabine (Astarabine, BST236) is a cytarabine conjugate that shows anti-neoplastic agents for inhibiting cancer cell growth. . |
| PC-35560 |
Elacytarabine
|
Elacytarabine (CP-4055, CP4055, ELACYT) is a fatty acid derivative of cytarabine with potential antineoplastic activity. |
| PC-44249 |
RX-3117
|
RX-3117 (TV-1360, fluorocyclopentenylcytosine) is an orally available cytidine analog, nucleoside antimetabolite with potential antineoplastic activity. |
| PC-35236 |
DFP-10917
|
DFP-10917 (CNDAC, TAS-109) is a deoxycytidine analog with antitumor activity against various tumor cells. |
| PC-43524 |
Zebularine
|
Zebularine (NSC309132, 4-Deoxyuridine) is a nucleoside analog of cytidine and inhibitor of cytidine deaminase, also inhibits DNA methylation and tumor growth both in vitro and in vivo.. |
| PC-63498 |
TAS-114
|
TAS-114 is a first-in-class, potent, dual dUTPase/DPD inhibitor with Ki of 0.13/2.14 uM, respectively. |
| PC-63014 |
Metesind glucuronate
|
Metesind glucuronate (AG 331. |
